IBA sees barriers falling as proton beams tested in more cancers
By Ben Hirschler
6 a.m. September 10, 2015
Proton-beam therapy may need the world's most expensive medical machines but barriers to its use are falling fast as doctors test the super precise form of radiation in the treatment of a widening range of cancers, according to the leader in the field.
Belgium's Ion Beam Applications (IBA) finance chief Jean-Marc Bothy said, "We don't see any exhaustion of the pipeline at all. It's very promising how new opportunities are developing, while existing ones continue."
It isn't just the market that is growing, but the number of clinical trials. An increasing number of studies outside of the traditional treatment sites (brain, ocular, pediatrics, and prostate) are being explored.